Elsevier
International Journal of Radiation Oncology Biology Physics
,  volume 121 ,  issue 3 ,  pages 693-702

STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL

Gabriella Macchia 1, 2
, 
Maura Campitelli 3
, 
D Pezzulla 4
, 
Simona Lucci 3
, 
Fodor A 5
, 
Donatella Russo 6
, 
Vittoria Balcet 7
, 
Paolo Bonome 8
, 
Stefano Durante 9
, 
Lorena Draghini 10
, 
Francesca Titone 11
, 
Giuseppe D’Agostino 12
, 
Giuseppe R. D'Agostino 12
, 
Marinella Tamburo 13
, 
Martina Ferioli 14
, 
Edy Ippolito 15
, 
Francesca Tortoreto 16
, 
Luciana Caravatta 17
, 
F. de Felice 18
, 
Aida Di Stefano 19
, 
Mara Fanelli 20
, 
Savino Cilla 21
, 
Francesco Cosentino 22
, 
Claudia Marchetti 23
, 
Vanda Salutari 23
, 
Serena Boccia 23
, 
Alessio Giuseppe Morganti 24
, 
MARIA ANTONIETTA GAMBACORTA 25
, 
A. Fagotti 23
, 
S. Pignata 26
, 
Sandro Pignata 26
, 
Giovanni Scambia 23
, 
Gabriella Ferrandina 1
, 
Francesco Deodato 27
1
 
UOC Ginecologia Oncologica, Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Electronic address: gabriella.ferrandina@gmail.com. | 
2
 
Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy. Electronic address: gabriella.macchia@responsible.hospital.
3
 
4
 
Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy. Electronic address: donato.pezzulla@responsible.hospital.
5
 
6
 
Radiotherapy Unit, Ospedale "Vito Fazzi", Lecce, Italy. | 
7
 
UOC Radioterapia, Nuovo Ospedale degli Infermi, Biella, Italy. | 
8
 
Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy. | 
9
 
10
 
Radiation Oncology Center, S Maria Hospital, Terni, Italy. | 
11
 
Department of Radiation Oncology, University Hospital Udine, Italy. | 
12
 
13
 
U.O.C. di Radioterapia, Azienda Ospedaliera "Cannizzaro" - Catania. | 
14
 
15
 
16
 
UOC di Radioterapia Fatebenefratelli Isola Tiberina. Gemelli Isola, Rome, Italy. | 
17
 
Department of Radiation Oncology, SS Annunziata Hospital, Chieti, Italy. | 
18
 
19
 
Medical Oncology Unit, Responsible Research Hospital, Campobasso, Molise, Italy. | 
20
 
Research Laboratories, Responsible Research Hospital, Campobasso, Molise, Italy. | 
21
 
Medical Physics Unit, Responsible Research Hospital, Campobasso, Molise, Italy. | 
22
 
23
 
UOC Ginecologia Oncologica, Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. | 
24
 
25
 
26
 
27
 
Publication type: Journal Article
Publication date: 2025-03-01
Elsevier
scimago Q1
wos Q1
SJR: 2.058
CiteScore: 10.9
Impact factor: 6.5
ISSN: 03603016, 1879355X
Abstract
MITO-RT3/RAD (NCT04593381) is a prospective multicenter Phase II trial designed to assess the effectiveness and safety of stereotactic body radiotherapy (SBRT) in patients diagnosed with oligometastatic ovarian cancer (oligo-MPR-OC). In this report, we provide the results of the trial in the setting of lymph node disease.
Found 
Found 

Top-30

Journals

1
2
3
International Journal of Radiation Oncology Biology Physics
International Journal of Radiation Oncology Biology Physics, 3, 42.86%
International Journal of Radiation Oncology Biology Physics
3 publications, 42.86%
Cancer Letters
Cancer Letters, 1, 14.29%
Cancer Letters
1 publication, 14.29%
Gynecologic Oncology
Gynecologic Oncology, 1, 14.29%
Gynecologic Oncology
1 publication, 14.29%
Frontiers in Pharmacology
Frontiers in Pharmacology, 1, 14.29%
Frontiers in Pharmacology
1 publication, 14.29%
Current Opinion in Obstetrics and Gynecology
Current Opinion in Obstetrics and Gynecology, 1, 14.29%
Current Opinion in Obstetrics and Gynecology
1 publication, 14.29%
1
2
3

Publishers

1
2
3
4
5
Elsevier
Elsevier, 5, 71.43%
Elsevier
5 publications, 71.43%
Frontiers Media S.A.
Frontiers Media S.A., 1, 14.29%
Frontiers Media S.A.
1 publication, 14.29%
Ovid Technologies (Wolters Kluwer Health)
Ovid Technologies (Wolters Kluwer Health), 1, 14.29%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 14.29%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Macchia G. et al. STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL // International Journal of Radiation Oncology Biology Physics. 2025. Vol. 121. No. 3. pp. 693-702.
GOST all authors (up to 50) Copy
Macchia G. et al. STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL // International Journal of Radiation Oncology Biology Physics. 2025. Vol. 121. No. 3. pp. 693-702.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ijrobp.2024.09.036
UR - https://linkinghub.elsevier.com/retrieve/pii/S0360301624034023
TI - STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL
T2 - International Journal of Radiation Oncology Biology Physics
AU - Macchia, Gabriella
AU - Campitelli, Maura
AU - Pezzulla, D
AU - Lucci, Simona
AU - A, Fodor
AU - Russo, Donatella
AU - Balcet, Vittoria
AU - Bonome, Paolo
AU - Durante, Stefano
AU - Draghini, Lorena
AU - Titone, Francesca
AU - D’Agostino, Giuseppe
AU - D'Agostino, Giuseppe R.
AU - Tamburo, Marinella
AU - Ferioli, Martina
AU - Ippolito, Edy
AU - Tortoreto, Francesca
AU - Caravatta, Luciana
AU - de Felice, F.
AU - Stefano, Aida Di
AU - Fanelli, Mara
AU - Cilla, Savino
AU - Cosentino, Francesco
AU - Marchetti, Claudia
AU - Salutari, Vanda
AU - Boccia, Serena
AU - Morganti, Alessio Giuseppe
AU - GAMBACORTA, MARIA ANTONIETTA
AU - Fagotti, A.
AU - Pignata, S.
AU - Pignata, Sandro
AU - Scambia, Giovanni
AU - Ferrandina, Gabriella
AU - Deodato, Francesco
PY - 2025
DA - 2025/03/01
PB - Elsevier
SP - 693-702
IS - 3
VL - 121
PMID - 39326506
SN - 0360-3016
SN - 1879-355X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Macchia,
author = {Gabriella Macchia and Maura Campitelli and D Pezzulla and Simona Lucci and Fodor A and Donatella Russo and Vittoria Balcet and Paolo Bonome and Stefano Durante and Lorena Draghini and Francesca Titone and Giuseppe D’Agostino and Giuseppe R. D'Agostino and Marinella Tamburo and Martina Ferioli and Edy Ippolito and Francesca Tortoreto and Luciana Caravatta and F. de Felice and Aida Di Stefano and Mara Fanelli and Savino Cilla and Francesco Cosentino and Claudia Marchetti and Vanda Salutari and Serena Boccia and Alessio Giuseppe Morganti and MARIA ANTONIETTA GAMBACORTA and A. Fagotti and S. Pignata and Sandro Pignata and Giovanni Scambia and Gabriella Ferrandina and Francesco Deodato and others},
title = {STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL},
journal = {International Journal of Radiation Oncology Biology Physics},
year = {2025},
volume = {121},
publisher = {Elsevier},
month = {mar},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0360301624034023},
number = {3},
pages = {693--702},
doi = {10.1016/j.ijrobp.2024.09.036}
}
MLA
Cite this
MLA Copy
Macchia, Gabriella, et al. “STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL.” International Journal of Radiation Oncology Biology Physics, vol. 121, no. 3, Mar. 2025, pp. 693-702. https://linkinghub.elsevier.com/retrieve/pii/S0360301624034023.